社保重仓
Search documents
云铝股份跌2.02%,成交额6.24亿元,主力资金净流出2690.18万元
Xin Lang Cai Jing· 2025-11-04 02:53
Core Viewpoint - Yun Aluminum Co., Ltd. has experienced significant stock price growth this year, with a year-to-date increase of 82.66% and notable gains over various trading periods [2]. Group 1: Stock Performance - As of November 4, Yun Aluminum's stock price was 23.80 CNY per share, with a trading volume of 624 million CNY and a market capitalization of 82.54 billion CNY [1]. - The stock has seen a 8.43% increase over the last 5 trading days, a 19.42% increase over the last 20 days, and a 54.05% increase over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Yun Aluminum reported a revenue of 44.072 billion CNY, representing a year-on-year growth of 12.47%, and a net profit attributable to shareholders of 4.398 billion CNY, which is a 15.14% increase year-on-year [2]. - The company has distributed a total of 6.069 billion CNY in dividends since its A-share listing, with 3.884 billion CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Yun Aluminum was 79,100, a decrease of 8.51% from the previous period, with an average of 43,857 circulating shares per shareholder, an increase of 9.30% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 269 million shares, an increase of 72.093 million shares from the previous period [3].
我武生物跌2.02%,成交额3554.66万元,主力资金净流出9.88万元
Xin Lang Cai Jing· 2025-11-04 01:55
Core Points - The stock price of Iwu Biotech has increased by 71.09% year-to-date, but has seen a recent decline of 2.58% over the last five trading days [2] - The company reported a revenue of 853 million yuan for the period from January to September 2025, representing a year-on-year growth of 16.86%, and a net profit of 345 million yuan, up 26.67% [2] - Iwu Biotech's main business revenue is primarily derived from dust mite drops (94.17%), followed by other products such as Artemisia annua flowers (4.35%) and skin prick liquid (1.31%) [2] Financial Performance - As of September 30, 2025, Iwu Biotech has a market capitalization of 18.006 billion yuan, with a trading volume of 35.5466 million yuan and a turnover rate of 0.21% [1] - The company has distributed a total of 913 million yuan in dividends since its A-share listing, with 317 million yuan distributed over the past three years [3] Shareholder Information - The number of shareholders as of September 30, 2025, is 32,400, a decrease of 6.22% from the previous period, while the average circulating shares per person increased by 6.63% to 14,927 shares [2] - Major shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 1.4524 million shares, and new entrants such as Harvest Mutual Fund [3]
天山铝业涨2.09%,成交额5.90亿元,主力资金净流出2931.96万元
Xin Lang Zheng Quan· 2025-11-03 05:56
Core Viewpoint - Tianshan Aluminum has shown significant stock performance with an 82.63% increase year-to-date, reflecting strong market interest and financial growth [1][2]. Financial Performance - For the period from January to September 2025, Tianshan Aluminum achieved a revenue of 22.32 billion yuan, representing a year-on-year growth of 7.34% [2]. - The net profit attributable to shareholders for the same period was 3.34 billion yuan, marking an 8.31% increase compared to the previous year [2]. Stock Market Activity - As of November 3, Tianshan Aluminum's stock price was 13.65 yuan per share, with a market capitalization of 63.498 billion yuan [1]. - The stock has experienced a recent trading volume of 5.90 billion yuan, with a turnover rate of 1.07% [1]. - Over the last five trading days, the stock price increased by 3.54%, and over the last 20 days, it rose by 23.50% [1]. Shareholder Information - As of September 30, the number of shareholders for Tianshan Aluminum was 37,800, a decrease of 23.85% from the previous period [2]. - The average number of circulating shares per shareholder increased by 31.32% to 109,224 shares [2]. Dividend Distribution - Tianshan Aluminum has distributed a total of 7.48 billion yuan in dividends since its A-share listing, with 4.38 billion yuan distributed over the last three years [3]. Major Shareholders - As of September 30, 2025, Hong Kong Central Clearing Limited was the seventh-largest circulating shareholder, holding 131 million shares, an increase of 18.54 million shares from the previous period [3].
工商银行涨2.06%,成交额18.93亿元,主力资金净流入1.41亿元
Xin Lang Cai Jing· 2025-11-03 05:35
Core Points - The stock price of Industrial and Commercial Bank of China (ICBC) increased by 2.06% on November 3, reaching 7.94 CNY per share, with a total market capitalization of 2829.87 billion CNY [1] - Year-to-date, ICBC's stock price has risen by 20.08%, with a 0.38% increase over the last five trading days, 7.15% over the last twenty days, and 4.20% over the last sixty days [1] - As of September 30, 2025, ICBC reported a net profit of 269.91 billion CNY, reflecting a year-on-year growth of 0.33% [2] Financial Performance - For the period from January to September 2025, ICBC achieved an operating revenue of 0.00 CNY, while the net profit attributable to shareholders was 2699.08 million CNY [2] - The bank has distributed a total of 1525.29 billion CNY in dividends since its A-share listing, with 327.15 billion CNY distributed over the past three years [2] Shareholder Information - As of September 30, 2025, the number of ICBC shareholders increased to 759,600, up by 12.74% from the previous period [2] - The average number of circulating shares per shareholder decreased by 13.25% to 409,802 shares [2] - Major shareholders include China Securities Finance Corporation and Hong Kong Central Clearing Limited, with notable changes in their holdings [2]
欧派家居跌2.04%,成交额4536.42万元,主力资金净流入321.31万元
Xin Lang Cai Jing· 2025-11-03 02:29
Core Viewpoint - The stock price of Oppein Home has experienced a decline of 21.15% year-to-date, with a recent drop of 2.04% on November 3, 2023, indicating potential challenges in the company's market performance [1]. Financial Performance - For the period from January to September 2025, Oppein Home reported a revenue of 13.214 billion yuan, representing a year-on-year decrease of 4.79%. The net profit attributable to shareholders was 1.832 billion yuan, down 9.77% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 7.234 billion yuan, with 4.249 billion yuan distributed over the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Oppein Home is 20,700, a decrease of 1.78% from the previous period. The average number of circulating shares per person has increased by 1.81% to 29,382 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 11.1909 million shares, a reduction of 488,600 shares from the previous period. New shareholders include ICBC Value Selection Mixed A and several ETFs [3]. Market Activity - On November 3, 2023, Oppein Home's stock traded at 52.41 yuan per share, with a total market capitalization of 31.926 billion yuan. The trading volume was 45.3642 million yuan, with a turnover rate of 0.14% [1]. - The net inflow of main funds was 3.2131 million yuan, with large orders accounting for 15.40% of purchases and 8.32% of sales [1]. Business Overview - Oppein Home, established on July 1, 1994, and listed on March 28, 2017, specializes in personalized design, research and development, production, sales, installation, and interior decoration services for whole-home furniture products. The main revenue sources include wardrobes and matching furniture (51.74%), cabinets (28.80%), wooden doors (6.00%), and bathrooms (5.74%) [1]. - The company operates within the light industry manufacturing sector, specifically in customized home products, and is associated with concepts such as C2M, customized home, and mid-cap stocks [1].
威尔药业的前世今生:2025年三季度营收10.18亿行业排17,低于行业平均4.48亿
Xin Lang Zheng Quan· 2025-10-31 15:57
Core Viewpoint - 威尔药业 is a significant player in the pharmaceutical excipients and synthetic lubricants sector in China, showcasing strong R&D capabilities and product quality advantages. Group 1: Company Overview - 威尔药业 was established on February 18, 2000, and was listed on the Shanghai Stock Exchange on January 30, 2019, with its registered and office locations in Nanjing, Jiangsu Province [1]. - The company primarily engages in the R&D, production, and sales of pharmaceutical excipients and synthetic lubricants, classified under the pharmaceutical and biological industry [1]. Group 2: Financial Performance - In Q3 2025, 威尔药业 reported a revenue of 1.018 billion yuan, ranking 17th among 47 companies in the industry, with the industry leader, 普洛药业, generating 7.764 billion yuan [2]. - The net profit for the same period was 112 million yuan, placing 威尔药业 at 16th in the industry, while the top performer, 浙江医药, achieved a net profit of 867 million yuan [2]. Group 3: Financial Ratios - As of Q3 2025, 威尔药业's debt-to-asset ratio was 31.69%, an increase from 26.48% year-on-year, and above the industry average of 27.75% [3]. - The gross profit margin for Q3 2025 was 28.48%, up from 25.93% year-on-year, but still below the industry average of 35.38% [3]. Group 4: Executive Compensation - The chairman, 吴仁荣, received a salary of 1.0133 million yuan in 2024, reflecting an increase of 22,600 yuan from 2023 [4]. Group 5: Shareholder Information - As of September 30, 2025, 威尔药业 had 6,776 A-share shareholders, a 5.36% increase from the previous period, with an average of 20,000 circulating A-shares held per shareholder, down by 5.09% [5]. - The company is focusing on dual growth drivers from synthetic lubricants and pharmaceutical excipients, with strategic initiatives in high-tech sectors and high-value new products [5].
永兴股份的前世今生:2025年前三季度营收32.5亿行业排名13,净利润7.58亿行业排名9,毛利率43.82%高于行业平均
Xin Lang Cai Jing· 2025-10-31 13:21
Core Viewpoint - Yongxing Co., Ltd. is a leading waste treatment company in Guangzhou, focusing on waste incineration power generation, with high capacity utilization and cost control advantages [1] Group 1: Company Overview - Yongxing Co., Ltd. was established on May 21, 2009, and is listed on the Shanghai Stock Exchange as of January 18, 2024 [1] - The company is categorized under the environmental protection industry, specifically in waste management, and is involved in waste incineration power generation and biomass treatment [1] Group 2: Financial Performance - For Q3 2025, Yongxing reported revenue of 3.25 billion yuan, ranking 13th in the industry, while the net profit was 758 million yuan, ranking 9th [2] - The industry leader, Zhejiang Fu Holdings, had a revenue of 16.155 billion yuan, and the average revenue in the industry was 3.334 billion yuan [2] Group 3: Financial Ratios - As of Q3 2025, Yongxing's debt-to-asset ratio was 57.27%, higher than the industry average of 50.06% [3] - The gross profit margin for Q3 2025 was 43.82%, exceeding the industry average of 25.02% [3] Group 4: Management and Shareholder Information - The total compensation for General Manager Tan Qiang in 2024 was 1.4541 million yuan, an increase of 440,500 yuan from 2023 [4] - The largest shareholder is Guangzhou Environmental Investment Group, with the actual controller being the Guangzhou Municipal Government [4] Group 5: Shareholder Dynamics - As of September 30, 2025, the number of A-share shareholders decreased by 3.42% to 29,400 [5] - The average number of circulating A-shares held per shareholder increased by 3.54% to 8,174.39 [5] Group 6: Business Highlights and Future Outlook - The increase in revenue and net profit for the first three quarters of 2025 was attributed to higher waste intake and the consolidation of Jiejin Company [5] - Forecasts for 2025-2027 project revenues of 4.134 billion yuan, 4.387 billion yuan, and 4.751 billion yuan, with net profits of 932 million yuan, 1.062 billion yuan, and 1.170 billion yuan respectively [5] - East Wu Securities noted improvements in gross margin and return on equity, with a decrease in capital expenditure and a 16.9% increase in free cash flow [6]
凯立新材的前世今生:营收行业第28,净利润行业第30,2025Q2业绩同环比增长,看好长期成长性
Xin Lang Cai Jing· 2025-10-31 13:15
Core Viewpoint - Kaili New Materials is a leading domestic supplier of precious metal catalysts with strong technical capabilities and a comprehensive industry chain advantage, focusing on research, production, and recycling of precious metal catalysts [1] Group 1: Business Performance - In Q3 2025, Kaili New Materials reported revenue of 1.435 billion yuan, ranking 28th in the industry, below the industry average of 1.994 billion yuan [2] - The net profit for the same period was 82.96 million yuan, ranking 30th in the industry, slightly above the industry average of 74.44 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, the company's debt-to-asset ratio was 49.02%, higher than the previous year's 44.81% and above the industry average of 34.74% [3] - The gross profit margin for Q3 2025 was 12.64%, an increase from 11.31% year-on-year, but still below the industry average of 19.93% [3] Group 3: Executive Compensation - The chairman, Zeng Yongkang, received a salary of 499,400 yuan in 2024, an increase of 149,700 yuan from 2023 [4] - The general manager, Wan Kerou, earned 541,100 yuan in 2024, up by 211,900 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 3.04% to 6,026, while the average number of circulating A-shares held per account decreased by 2.95% to 21,700 [5] Group 5: Business Highlights - In H1 2025, the overall sales volume of catalyst products increased by 122.33% year-on-year, with significant growth across multiple sectors [5] - The company is making progress in new product development, including high-performance catalysts and automation upgrades for production lines [6]
长华化学的前世今生:2025年三季度营收19.91亿排行业20,净利润7606.74万排33
Xin Lang Cai Jing· 2025-10-31 13:09
Core Viewpoint - Changhua Chemical, established in 2010 and listed on the Shenzhen Stock Exchange in 2023, is a significant player in the domestic polyether product sector, known for its technological advantages and stable product quality [1] Group 1: Business Overview - Changhua Chemical's main business includes the research, production, and sales of polyether products, classified under the basic chemical industry [1] - The company is part of several concept sectors, including new materials, share buybacks, social security heavy holdings, nuclear fusion, superconductivity, and nuclear power [1] Group 2: Financial Performance - For Q3 2025, Changhua Chemical reported a revenue of 1.991 billion yuan, ranking 20th among 79 companies in the industry, with the industry leader, Sinochem International, generating 35.716 billion yuan [2] - The net profit for the same period was 76.0674 million yuan, placing it 33rd in the industry, while the top performer, Hangyang Co., reported a net profit of 850 million yuan [2] Group 3: Financial Ratios - As of Q3 2025, Changhua Chemical's debt-to-asset ratio was 43.98%, exceeding the industry average of 34.74%, and significantly higher than the previous year's 14.52% [3] - The gross profit margin for Q3 2025 was 7.12%, below the industry average of 19.93%, and an increase from 3.95% in the previous year [3] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 45.12% to 14,000, while the average number of circulating A-shares held per account decreased by 31.09% to 3,806 [5]
江南水务的前世今生:2025年三季度营收低于行业平均,净利润高于行业中位数
Xin Lang Zheng Quan· 2025-10-31 12:16
Core Viewpoint - Jiangnan Water is a leading company in the domestic water supply industry, focusing on water production and treatment, with significant operational capacity and market presence [1] Company Overview - Jiangnan Water was established on July 15, 2003, and listed on the Shanghai Stock Exchange on March 17, 2011, with its headquarters in Jiangyin, Jiangsu Province [1] - The company specializes in the production and sale of tap water and related water treatment services, with a daily water supply capacity of 930,000 cubic meters and a supply network exceeding 600 kilometers [1] Financial Performance - For Q3 2025, Jiangnan Water reported revenue of 1.039 billion yuan, ranking 23rd out of 51 in the industry, significantly lower than the top competitor, Beijing Capital Eco-Environment Protection Group, which had revenue of 13.453 billion yuan [2] - The net profit for the same period was 275 million yuan, ranking 12th in the industry, again lower than the leading competitors [2] Financial Ratios - As of Q3 2025, Jiangnan Water's debt-to-asset ratio was 35.38%, down from 38.25% year-on-year and below the industry average of 49.82%, indicating strong solvency [3] - The gross profit margin for Q3 2025 was 39.39%, an increase from 37.55% year-on-year and above the industry average of 32.13%, reflecting robust profitability [3] Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 9.94% to 22,300, while the average number of circulating A-shares held per shareholder increased by 11.03% to 42,000 [5]